Investing in family farming values
120 Years of Agricultural Experience
The Geen family has been actively farming in the Okanagan for 5 generations, successfully operating tree fruit orchards, vineyards, and ground crop plantations.
290 Acres for Outdoor Cultivation
SpeakEasy successfully completed it's 2020 outdoor harvest with a total yield of 72,000 KG. The Company plans to double the yield for the 2021 season.
If we look at our current competitor's multiplier of revenue to establish market capitalization, the Company believes even with a modest harvest in the next 12 months SpeakEasy is poised to become a top contender.
Resources for Investors
Request the Investor Presentation
Download SpeakEasy's investor presentation to see the upcoming major milestones, the countdown to the massive harvest, brand launches, and more!Download Now
SpeakEasy to Enter Psychedelics Sector With Narcotics Dealers Licence with a Focus on PsilocybinRead More
SPEAKEASY ANNOUNCES ENTERING FINAL STAGE OF AMENDED SALES LICENSING FOR EXTRACTS AND CONCENTRATESRead More
SPEAKEASY REPORTS EARNINGS FOR IT‘S FIRST QUARTER OF SALES AND RELEASES QUARTER TWO FINANCIAL RESULTSRead More
SPEAKEASY ANNOUNCES IT IS NOW REGISTERED AND LICENCED TO SELL IN THE PROVINCE OF SASKATCHEWANRead More
SPEAKEASY OPENS FIRST OF THREE 13,300 SQ FT LICENSED INDOOR GROW FACILITIES FOR PRODUCTION OF CRAFT STYLE FLOWERRead More
SPEAKEASY PROVES HIGH QUALITY HIGH MARGIN PRODUCT STRATEGY WITH ITS INDOOR CRAFT FLOWER SALES AND OUTLOOK FOR 2021Read More
SPEAKEASY ANNOUNCES HEALTH CANADA HAS GRANTED AN AMENDMENT TO ITS SALES LICENCE TO SELL DRIED CANNABIS FLOWER AND PRODUCTSRead More
SPEAKEASY EXCEEDS PROJECTED ESTIMATES WITH 72,000 KILOGRAMS ON COMPLETION OF 2020 OUTDOOR HARVESTRead More
SPEAKEASY HAS RECEIVED HEALTH CANADA APPROVAL TO OPERATE ITS 53,200 SQ FT PRODUCTION AND PROCESSING FACILITY OPENING THE DOOR TO A RAPIDLY GROWING MARKETRead More
SPEAKEASY IS FIVE WEEKS AWAY FROM HARVESTING ONE OF THE LARGEST SINGLE OUTDOOR CANNABIS CROPS IN CANADIAN HISTORYRead More
SPEAKEASY ENTERS INTO LICENSE AGREEMENT WITH PHENOME ONE FOR CANNABIS CULTIVARS AND ANNOUNCES LEADERSHIP TRANSITIONRead More
SpeakEasy Updates Prior Public Disclosure and Announces Approval of Settlement Agreement with the BCSCRead More
SPEAKEASY SIGNS LOI WITH CHRISTINA LAKE CANNABIS ON A JOINT VENTURE AND ANNOUNCES ISSUANCE OF SHARESRead More
SPEAKEASY ANNOUNCES ITS SUBMISSION FOR AN AMENDMENT TO ITS LICENCE TO INCLUDE ITS 60-ACRE FIELD FOR OUTDOOR CULTIVATIONRead More
SPEAKEASY ANNOUNCES COMPLETION OF MOVING ITS GENETICS CATALOGUE INTO ITS FACILITY IN ANTICIPATION OF RECEIVING ITS CULTIVATION LICENSERead More
SpeakEasy Announces the Addition of John Karroll to Its Advisory Board and Provides Clarity on Management Cease Trade OrderRead More
Speakeasy Announces Change to Its Board of Directors and an Increase to Its Previously Announced Non-Brokered Private PlacementRead More
SpeakEasy Signs a MOU to Bring Premium Cannabis to Germany and the European Union with HerbaMedica GmbHRead More
SPEAKEASY ENTERS INTO CANNABIS SUPPLY AGREEMENT WITH VALENS, ARRANGES LD APPLICATION AND SITE EXTENSIONRead More
Phase 2 Update: 80,000 SQFT “Cannabis Complex” to Produce Premium Small-Batch Product from BC’s Best GrowersRead More
Marc Geen, Founder & Adviser to the Board of Directors
A proud 4th-generation BC farmer, Marc Geen has been active in the legal medical marijuana industry for more than 10 years, consulting, complying with, and participating in the MMAR, MMPR, and ACMPR programs. Prior to co-founding Speakeasy Cannabis Club Ltd., Marc spent 17 years as Head of Operations for Kettle Mountain Ginseng Ltd, one of North Americas largest ginseng producers. The experience gleaned from a long career in large scale commercial farming, Mr. Geen has been able to apply many cost effective, good farming practices to the outdoor, indoor, and greenhouse cultivation of cannabis. Mr. Geen is also the co-creator of a full line of cannabis extract products designed under ACMPR regulations.
Malcolm Davidson – CPA, CA
Mr. Davidson is a career CFO and with more than 17 years of professional accounting and finance experience. Over the past year, Mr. Davidson has been the CFO for publicly traded cannabis companies. Prior to this, much of his experience has been providing CFO services to producing publicly traded mining companies that trade on the TSX and NYSE. In addition to financial reporting, Malcolm brings a wealth of knowledge to directing the regulatory and compliance environment for the Company but also works closely with the executive team to ensure that It meets Its short and long term objectives. As a seasoned professional accountant, Malcolm looks forward to bringing his tax, finance, and assurance skillset to SpeakEasy.
Dr. Huang joined SpeakEasy in June 2019 as CEO. She is a seasoned life-sciences executive with experience in strategy and new business development, financing and public markets, corporate governance, as well as operations management in North America and Asia. Her work experience includes 18 years as CEO of life-sciences companies, most recently CEO of Emerald Health Therapeutics Inc., senior management roles in both startups and Fortune 500 corporations, analyst and partner at a premier investment banking firm. Dr. Huang has also served on the board of several public and private companies as well as NGOs, currently serving as chair of the board of directors of OncoQuest Inc. Dr. Huang holds a PhD in cell biology (University of East Anglia, UK) and an MBA in finance (University of Toronto, Canada).
CSO & Director
Dr. Garabagi currently serves as Chief scientific Officer for SpeakEasy Cannabis Club and Island Canna Seeds. He is a research scientist, inventor, and entrepreneur in the field of plant molecular genetics and biotechnology with 10 years of post-doctoral research experience from the University of Guelph. Prior to joining SpeakEasy, he was VP of Research and Quality Affairs at Emerald Health Therapeutics Inc. from September 2015 to January 2019. Dr. Garabagi founded Herbaceous Inc. in 2012 to organize preclinical research with non-psychoactive cannabinoids on epilepsy and obesity. The company received its right-to-build letter from Health Canada in February 2014 and completed securing a $6M financing in 2015 for the construction of its facility.
Interim CFO & Director
Patrick Geen is a co-founder and facility manager at Speakeasy Cannabis Club Ltd. Before relocating to Rock Creek to begin work at Speakeasy Patrick spent the previous 10 years as an Aircraft Maintenance Engineer-Avionics in the aerospace industry at Kelowna Flightcraft after graduating at the top of his class from BCIT. Prior to that he spent 14 years as a plant science technologist at Kettle Mountain Ginseng Ltd, one of North Americas largest ginseng producers.
Mr. Fleming has founded and served as CEO for a number of entrepreneurial companies and has served with senior executive teams dealing with equity and debt financings. Mr. Fleming has developed corporate strategies for a wide range of companies, from family-owned businesses to multi-national companies. Bill currently serves as President of Mernova Medicinal Inc. which recently sold to Switzerland based Creso Pharma Limited. Mr. Fleming is the Executive Chairman of Mountain Lake Minerals and was CEO and Director of a cannabis company. He most recently served as the CFO and Director of NWest Energy Corp. Mr. Fleming has experience raising equity for small cap companies and has experience in mineral exploration, renewable energy and the cannabis industry.
Corporate Compliance Officer
Ms. Cotter joined SpeakEasy in July 2018. She has vast experience in the public markets serving in the capacity of Corporate Secretary and Corporate Compliance Officer for over 20 years. She currently serves as Corporate Secretary to Terrace Energy Corp. and Enviro Metals Corporation, and prior to that she was Corporate Secretary of CRH Medical Corporation from January 2006 until January 2011 and Corporate Secretary of ID Biomedical Corporation from January 1999 until December 2005, the time of its takeover offer by GlaxoSmithKline plc. ID Biomedical grew from an Initial $3 million market capitalization to $1.7 billion at the time of its takeover offer in 2005.
Be a Part of the Conversation
We would like to invite you to ask us anything! We’ll compile all the questions, and at the end of every quarter they will be addressed by Marc Geen and Malcolm Davidson in the section below.